The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Of Georgia Group Regulatory News (BGEO)

Share Price Information for Bank Of Georgia Group (BGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,940.00
Bid: 4,960.00
Ask: 4,970.00
Change: 90.00 (1.86%)
Spread: 10.00 (0.202%)
Open: 4,890.00
High: 5,020.00
Low: 4,840.00
Prev. Close: 4,850.00
BGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BOG raises local currency funding from Symbiotics

21 Feb 2018 07:00

RNS Number : 4916F
Bgeo Group PLC
21 February 2018
 

 

 

 

 

 

London, 21 February 2018

 

JSC Bank of Georgia raises GEL 25 million local currency funding from Symbiotics

BGEO Group PLC (the "Group" or "BGEO"), announces that its banking business subsidiary, JSC Bank of Georgia (the "Bank of Georgia") has signed a loan agreement with Symbiotics ("the Company") - a Swiss investment company active in emerging and frontier economies. The GEL-denominated loan facility, totaling GEL 25 million (US$10 million) and with a maturity of two to three years, will be used to support Georgia's micro, small and medium sized enterprises with their increasing local currency financing needs.

 

 

Kaha Kiknavelidze, Bank CEO commented: "I am pleased that Bank of Georgia continues to actively establish new partnerships with financial institutions in order to secure local currency financial solutions for its clients and further support the de-dollarisation process in the country. This local currency loan agreement is Bank of Georgia's first transaction with Symbiotics, and the first step towards long-term successful co-operation."

 

Daniel Schriber, Director of Investments at Symbiotics noted: "We are very proud to partner with such a reputable and leading financial institution as Bank of Georgia, and glad to support the growth of Georgian micro, small and medium sized enterprises via this local currency loan in the context of the de-dollarisation of the country."

 

 

 

 

 

Name of authorised official of issuer responsible for making notification: Natia Kalandarishvili, Head of Investor Relations and Funding

 

 

About the Symbiotics Group

Symbiotics, incorporated in 2004 in Geneva, is an investment company specialised in emerging, sustainable and inclusive finance which offers market research, investment advisory and asset management services. It is an asset manager of collective investment schemes regulated by FINMA, the Swiss Financial Market Supervisory Authority and has an advisory license from the FCA, the Financial Conduct Authority, through its subsidiary in the UK. The company is headquartered in Geneva, with offices in Cape Town, London, Amsterdam, Zurich, Mexico City, Singapore, with a staff of over 130 professionals. Since 2004, Symbiotics has invested over US$ 4 billion in more than 375 microfinance institutions in 68 emerging countries, working with 44 investment funds and many institutional investors.

 

 

About BGEO Group PLC

The Group: BGEO Group PLC ("BGEO"- LSE: BGEO LN) is a UK incorporated holding company of a Georgia-focused investment platform. BGEO invests, via its subsidiaries, in the banking and non-banking sectors in Georgia (BGEO and its subsidiaries, together the "Group"). BGEO aims to deliver on its strategy of: (1) at least 20% ROAE from its Banking Business; (2) 15%-20% growth of its Banking Business loan book; (3) at least 25% IRR; and (4) up to 20% of the Group's profit from its Investment Business. On 3 July 2017 BGEO announced its intention to demerge BGEO Group PLC into a London-listed banking business (the "Banking Business") and a London-listed investment business (the "Investment Business") by the end of the first half of 2018. 

Banking Business: Currently comprises: a) retail banking and payment services, b) corporate investment banking and wealth management operations and c) banking operations in Belarus ("BNB"). JSC Bank of Georgia ("BOG" or the "Bank") is the core entity of the Group's Banking Business. The Banking Business will continue to target to benefit from the underpenetrated banking sector in Georgia primarily through its retail banking services.

Investment Business: Currently comprises the Group's stakes in Georgia Healthcare Group PLC ("Healthcare Business" or "GHG") - an LSE (a London Stock Exchange) premium-listed company, Georgia Global Utilities ("Utility and Energy Business" or "GGU"), m2 Real Estate ("Real Estate Business" or "m2"), Teliani Valley ("Beverage Business" or "Teliani") and Aldagi ("Property and Casualty Insurance Business" or Aldagi"). Georgia's fast-growing economy provides opportunities in a number of underdeveloped local markets and the Investment Business will target to capture growth opportunities in the Georgian corporate sector.

 

JSC BGEO Group has, as of the date hereof, the following credit ratings:

Bank of Georgia has, as of the date hereof, the following credit ratings:

Fitch Ratings

'BB-/B'

Fitch Ratings

'BB-/B'

Moody's

B1/NP (FC) & B1/NP (LC)

Moody's

'Ba3/NP' (FC) & 'Ba2/NP' (LC)

 

For further information, please visit www.bgeo.com or contact: 

Irakli Gilauri

Michael Oliver

Giorgi Alpaidze

Group CEO

Adviser to the CEO

Group CFO

+995 322 444 109

+44 203 178 4034

+995 322 444 190

igilauri@bgeo.com

moliver@bgeo.com

g.alpaidze@bgeo.com

 

 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKAFASFPEEF
Date   Source Headline
10th May 20244:57 pmRNSTransaction in Own Shares
9th May 20245:03 pmRNSTransaction in Own Shares
8th May 20245:04 pmRNSTransaction in Own Shares
7th May 20245:04 pmRNSTransaction in Own Shares
3rd May 20245:33 pmRNSTransaction in Own Shares
2nd May 20244:56 pmRNSTransaction in Own Shares
1st May 20245:13 pmRNSTransaction in Own Shares
1st May 20241:49 pmRNSCancellation of own shares
1st May 202412:19 pmRNSTotal Voting Rights
30th Apr 20245:06 pmRNSTransaction in Own Shares
29th Apr 20245:15 pmRNSTransaction in Own Shares
26th Apr 20245:03 pmRNSTransaction in Own Shares
25th Apr 20245:15 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSBank of Georgia Group PLC publishes Annual Report
24th Apr 20245:22 pmRNSTransaction in Own Shares
23rd Apr 20245:11 pmRNSTransaction in Own Shares
22nd Apr 20244:56 pmRNSTransaction in Own Shares
19th Apr 20245:19 pmRNSTransaction in Own Shares
19th Apr 20242:06 pmRNSDirector/PDMR Shareholding
18th Apr 20245:05 pmRNSTransaction in Own Shares
17th Apr 20245:16 pmRNSTransaction in Own Shares
16th Apr 20244:46 pmRNSTransaction in Own Shares
15th Apr 20245:27 pmRNSTransaction in Own Shares
15th Apr 20242:57 pmRNSDirector/PDMR Shareholding
12th Apr 20245:09 pmRNSTransaction in Own Shares
11th Apr 20245:09 pmRNSTransaction in Own Shares
10th Apr 20245:17 pmRNSTransaction in Own Shares
10th Apr 20247:00 amRNSJSC Bank of Georgia priced $300m AT1 capital notes
9th Apr 20245:07 pmRNSTransaction in Own Shares
8th Apr 20244:55 pmRNSTransaction in Own Shares
8th Apr 20241:29 pmRNSDirector/PDMR Shareholding
8th Apr 202412:47 pmRNSChange of Registered Office
4th Apr 20245:08 pmRNSTransaction in Own Shares
4th Apr 20242:51 pmRNSCancellation of own shares
3rd Apr 20245:09 pmRNSTransaction in Own Shares
3rd Apr 20244:00 pmRNSClosing of Acquisition of Ameriabank
2nd Apr 20245:26 pmRNSTransaction in Own Shares
2nd Apr 20243:26 pmRNSDirector/PDMR Shareholding
2nd Apr 20242:37 pmRNSTotal Voting Rights
2nd Apr 20247:15 amRNSMoody's upgrades Bank of Georgia's outlook
2nd Apr 20247:00 amRNSUpdate on Acquisition of Ameriabank
28th Mar 20245:29 pmRNSTransaction in Own Shares
27th Mar 20245:36 pmRNSTransaction in Own Shares
26th Mar 20245:09 pmRNSTransaction in Own Shares
25th Mar 20245:04 pmRNSTransaction in Own Shares
25th Mar 202412:13 pmRNSDirector/PDMR Shareholding
22nd Mar 20245:15 pmRNSTransaction in Own Shares
21st Mar 20245:16 pmRNSDirector/PDMR Shareholding
21st Mar 20245:11 pmRNSTransaction in Own Shares
20th Mar 20245:23 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.